Abstract:Abstract Background: Colorectal cancer (CRC) is one of the leading causes of cancer death in Puerto Rico (PR) and U.S. Approximately 5-10% of all CRC cases are due to hereditary CRC syndromes. Some of the most common hereditary colorectal cancer syndromes include: Familial Adenomatous Polyposis (APC), Lynch Syndrome (MLH1, MSH2, MSH6, PMS2) and MUTYCH (MYH). Germline genetic testing is the gold standard for diagnosing these syndromes. The implications of obtaining a Variant of Uncertain Significance (VUS) in germline genetic testing results remains a clinical challenge especially among minority Hispanic populations. The aim of this project was to determine the prevalence of germline pathogenic mutations and VUS in CRC-risk genes; as well as the phenotype of Hispanic patients with suspected Hereditary CRC syndromes. Methods: Germline genetic testing from patients with suspected hereditary CRC syndromes seen at the UPR Cancer Genetic Clinic during the period of 2015-2018 were evaluated. Sociodemographics, clinical, tumor and genetic testing data were accessed through the subject’s medical record. Descriptive statistics and frequency distribution tables were generated with the subject’s sociodemographic and clinical information, as well as germline genetic testing results. Results: A total of 91 patients (61.5% female; mean age 51 years) with suspected hereditary CRC syndromes were tested for germline mutations in relevant CRC-risk genes. The most common malignancies reported were CRC (80%) and endometrial cancer (12%). The majority of patients (n=60) did not have germline mutations in hereditary CRC-risk genes. Mutations in CRC-risk genes were detected in 22% of patients (50% MYH, 45% MMR, 5% APC), while VUSs were detected in 12% (18% MYH, 45% MMR, 36% APC). There were no statistically significant differences with regards to gender, age, personal history of cancer or 1st degree family history of cancer across study groups. All patients with VUSs in MMR-genes had microsatellite stable tumors; while those with mutations in MMR-genes had microsatellite unstable tumors. Conclusions: VUSs were present in a high-percentage of the patients evaluated for hereditary CRC syndromes. Furthermore, there were no phenotypical differences between patients with pathogenic mutations and those with VUSs. This presents a clinical challenge as non-European populations including Hispanics have genetic variances, which may in fact carry an increase risk for cancer. Future research is warranted to examine the significance and/or reclassify VUSs to improve assessment of genetic test results in admixed populations. Citation Format: Julyann Perez-Mayoral, Nicole Cruz-Reyes, Andrea Rosa-Vazquez, Maria Gonzalez-Pons, Marcia Cruz-Correa. Prevalence of germline mutations and variants of uncertain significance (VUS) among Hispanics with suspected hereditary colorectal cancer syndromes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4162.

Analysis of germline genetic variants that cause hereditary coloretal cancer in Bahia

Hereditary breast cancer next-generation sequencing (NGS) panel evaluation in the south region of Brazil: a novel candidate pathogenic variant is reported

Screening for Mutations in Hereditary Cancer Susceptibility Genes in a Region with High Endogamy in Brazil

Germline DNA Damage Repair Gene Alterations in Patients with Metachronous Breast and Colorectal Cancer

Somatic targeted mutation profiling of colorectal cancer precursor lesions

TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil

Abstract 4162: Prevalence of germline mutations and variants of uncertain significance (VUS) among Hispanics with suspected hereditary colorectal cancer syndromes

Germline Variants of <i>CYBA</i> and <i>TRPM4</i> Predispose to Familial Colorectal Cancer

Prevalence of germline variants in Brazilian pancreatic carcinoma patients

Germline variants in early and late-onset Brazilian prostate cancer patients

Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil

MUTYH-related polyposis syndrome associated with a variant of uncertain significance mutation: A new pathogenic mutation?

Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases

Mexican physicians' knowledge and attitudes towards hereditary colorectal cancer risk management.

Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes

Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients

Hereditary Colorectal Cancer and Polyposis Syndromes Caused by Variants in Uncommon Genes

Abstract 3947: Non-BRCA variants in hereditary breast and ovarian cancer patients in the Northern Mexico population

Clinical Assessment and Genetic Testing for Hereditary Polyposis Syndromes in an Italian Cohort of Patients with Colorectal Polyps

Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer

A Preliminary Comparative Analysis